From: New aspects of microbial vitamin K2 production by expanding the product spectrum
Vitamin K2 | Host | Pathway engineering | Strategies | Media | Titer | References |
---|---|---|---|---|---|---|
MK-7 and MK-9 | L. lactis | The MVA pathway, the polyprenyl pathway and the MK pathway | Overexpression of mvk, preA, and menA | M17 | 680Â nmol/L | [42] |
MK-4 | B. subtilis | The MVA and MEP pathway, the polyprenyl pathway and the MK pathway | Overexpression of menA, menG, crtE, dxs, dxr, ispD-F, mvaK1, mvaK2, mvaD, mvaS, mvaA | Fermentation medium | 120.1 ± 0.6 mg/L | [44] |
MK-4 | P. pastoris | The polyprenyl pathway | Expression of hsUBIAD1 | BMMY | 0.24Â mg/g DCW | [45] |
MK-7 | B. subtilis natto | – | Optimization of growth parameters | Fermentation medium | 12.09 mg/L | [55] |
MK-8 | E. coli | The SA pathway, the ubiquinone-8 pathway and the MK pathway | ubiCA deletion, overexpression of menA and menD | LGN | 290 μg/g WCW | [46] |
MK-7 | E. coli | The SA pathway | Overexpression aroA, aroK and the feedback inhibition-resistant aroGfbr | Â | 19.1Â mg/L | [64] |
MK-7 | B. subtilis | The MEP pathway and the MK pathway | The expression of menA-dxs-dxr-idi cassette | SYG | 50Â mg/L | [75] |
MK-7 | E. coli | The polyprenyl pathway and the MVA pathway | Overexpression of hepPPS and lower expression of mvaE, mvaS and mvK | Minimal medium added glucose | 2.3 μM | [77] |